or the corresponding 3′,5′-bisphosphate can be partially
separated by reverse phase HPLC. It was observed that two
stereoisomers coeluted while the two others were cleanly
resolved; no definitive stereochemical assignments were
made. With stereospecific syntheses of 1-4, we are now in
a position to assign the absolute stereochemistry of the
4-HNE adducts.
Scheme 3a
Using the published HPLC conditions we were able to
reproduce the reported elution profile. On the basis of the
HPLC retention times and published 1H NMR data, we have
established that the two resolved isomers are 3 and 4, derived
from the syn amino alcohols. This is consistent with the
previous observation that acid deglycosylation of these
isomers gave a single, presumably racemic guanine deriv-
ative.13a Interestingly, the reaction of racemic 4-HNE with
calf thymus DNA followed by digestion and analysis by
HPLC with 32P postlabeling detection has been reported to
give only two of the stereoisomers.13c On the basis of a
comparison of the reported HPLC retention time with our
own analysis, we tentatively assign the major adduct as 4
and the minor adduct as 3. It is worth noting that all four
stereoisomers have been detected from animal tissue using
the 32P postlabeling method, although not always in equal
concentrations.13c
Harris has shown that oligonucleotides containing an O6-
protected 2-fluoroinosine residue can undergo nucleophilic
aromatic substitution with aliphatic and aromatic amines to
give site-specifically adducted oligonucleotides.10 The O6-
protected 2-fluoroinosine was incorporated into oligonucleo-
tides using standard phosphoramidite chemistry. Reaction of
amino alcohols 8-11 with oligonucleotides containing
2-fluoroinosine followed by deprotection and periodate
cleavage should be a viable route to structurally and
stereochemically defined oligonucleotides containing 4-HNE
adducts. These modified oligonucleotides will be essential
for mutagenesis, repair, and structural studies on this
endogenous genotoxin.
a Reagents: (a) Ti(OiPr)4, tBuOOH, (+)-DIPT, CH2Cl2, -20 °C,
40%, 91% ee; (b) BnNCO, NaH, THF, reflux, 58%; (c) Ph3P, I2,
imidazole, 82%; (d) H2CdCHMgBr, CuI, HMPA, THF, 69%; (e)
OsO4, NMO, THF, tBuOH, H2O, 69%; (f) KOH, EtOH, reflux,
70%; (g) H2, Pd(OH)2, MeOH, 100%
give the corresponding N2-dG derivative (i.e., 21 from 9) in
57-64% yield after deprotection of the O6-(2-trimethylsilyl-
ethyl) group (Scheme 4). In the case of the syn amino
Scheme 4a
a Reagents: (a) iPr2NEt, DMSO, 70 °C; (b) 5% AcOH, 64%
from 5a; (c) NaIO4, H2O, 87%
alcohols, the minor stereoisomer from the Sharpless kinetic
resolution could be separated at this stage by HPLC.
Oxidative cleavage of the vicinal diol with sodium periodate
gave the 1,N2-propano adducts 1-4 in 80-87% yield.
Acknowledgment. We are grateful to Dr. Lubomir
Nechev, Dr. Ivan Kozekov, and Professors Tom and Connie
Harris for helpful suggestions. This work was supported by
the American Cancer Society (research grant RPG-96-061-
04-CDD) and the National Institutes of Health (research grant
ES05355 and center grant ES00267).
Methods have been developed for the detection of DNA
adducts of 4-HNE and related species.13 This involves
digestion of the oligonucleotide and analysis by HPLC. The
four stereoisomers of the 4-HNE-dG adduct at the nucleoside
1
Supporting Information Available: Copies of the H
and 13C NMR spectra of all new compounds and CD spectra
of 1-4. This material is available free of charge via the
(8) Winter, C. K.; Segall, H. J.; Haddon, W. F. Cancer Res. 1986, 46, 6,
5682.
(9) Khullar, S.; Varaprasad, C. V.; Johnson, F. J. Med. Chem. 1999, 42,
947.
(10) Nechev, L. V.; Harris, C. M.; Harris, T. M. Chem. Res. Toxicol.
2000, 13, 421.
(11) (a) Katsuki, T.; Martin, V. S. Org. React. 1996, 48, 1. (b) Gao, Y.;
Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, H.; Sharpless K. B.
J. Am. Chem. Soc. 1987, 109, 5765.
OL016810C
(13) (a) Douki, T,; Ames, B. N. Chem. Res. Toxicol. 1994, 7, 511. (b)
Yi, P.; Zhan, D.; Samokyszyn, V. M.; Doerge, D. R.; Fu, P. P. Chem. Res.
Toxicol. 1997, 10, 1259. (c) Chung, F.-L.; Nath, R. G.; Ocando, J.;
Nishikawa, A.; Zhang, L. Cancer Res. 2000, 60, 1507. (d) Wacker, M.;
Schuler, D.; Wanek, P.; Eder, E. Chem. Res. Toxicol. 2000, 13. 1165.
(12) (a) Ager, D. J.; Prakash, I.; Schaad, D. R. Chem. ReV. 1996, 96,
835. (b) Nagamitsu, T.; Sunazuka, T.; Tanaka, H.; Omura, S.; Sprengeler,
P. A.; Smith, A. B. J. Am. Chem. Soc. 1996, 118, 3584.
Org. Lett., Vol. 3, No. 22, 2001
3605